Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups-Reference-Cited by-同舟云学术

Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups

Published:2017-02-21 Issue:1 Volume:177 Page:106-115
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shankar Ananth G.¹,Roques Gaelle²,Kirkwood Amy A.³,Lambilliotte Anne⁴,Freund Katja¹,Leblanc Thierry⁵,Hayward Janis⁶,Abbou Samuel⁷,Ramsay Alan D.⁸,Schmitt Claudine⁹,Gorde-Grosjean Stephanie²,Pacquement Hélène¹⁰,Haouy Stephanie¹¹,Boudjemaa Sabah¹²,Aladjidi Nathalie¹³,Hall Georgina W.¹⁴,Landman-Parker Judith¹²

Affiliation:

1. Department of Paediatric and Adolescent Oncology; University College London Hospitals NHS Foundation Trust; London UK

2. CHU Reims; Reims France

3. Cancer Research UK & UCL Cancer Trials Centre; University College London; London UK

4. CHRU Lille; Lille France

5. AP-HP; Robert Debré Hospital; Paris France

6. Cancer Research UK Clinical Trials Unit; School of Cancer Sciences; University of Birmingham; Birmingham UK

7. Gustave Roussy; Villejuif France

8. Department of Cellular Pathology; University College London Hospitals NHS Foundation Trust; London UK

9. CHU Nancy; Nancy France

10. Insititut Curie; Paris France

11. CHU Montpellier; Montpellier France

12. Service d'hématologie et d'oncologie pédiatrique; Hopital A, Trousseau, 75571 APHP/UPMC Univ Paris 06; Paris France

13. CHU de Bordeaux; Bordeaux France

14. Paediatric Haematology/Oncology Unit; Children's Hospital, Oxford University Hospitals NHS Foundation Trust; Oxford UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14518/fullpdf

Reference39 articles.

1. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma;Advani;Hematological Oncology,2015

2. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma;Advani;Journal of Clinical Oncology,2014

3. High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma;Akhtar;Annals of Hematology,2016

4. Outcomes of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) vs. classical Hodgkin lymphoma (cHL) at Princess Margaret Cancer Centre;Ames;Blood,2015

5. Lymphocyte-predominant Hodgkin disease: a comprehensive overview;Bose;American Journal of Clinical Oncology,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma;Blood Cancer Journal;2024-05-31

2. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms;Modern Pathology;2024-04

3. Spatial Phenotyping of Nodular Lymphocyte Predominant Hodgkin Lymphoma and T-cell/Histiocyte-Rich Large B-cell Lymphoma;2023-11-29

4. Clinical possibilities of flow cytometry in hodgkin’s lymphoma;Oncohematology;2023-09-12

5. Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte‐predominant Hodgkin lymphoma: an IMPACT cohort study;British Journal of Haematology;2023-04-04